{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.159","meta":{"versionId":"6","lastUpdated":"2021-05-21T01:00:57.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Society of Clinical Oncology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-05-21"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.159","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.1444.3.159"}],"version":"20210521","name":"CabazitaxelInjectable","title":"Cabazitaxel Injectable","status":"active","experimental":false,"date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts of medication Cabazitaxel.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Cabazitaxel; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1001433","display":"1.5 ML cabazitaxel 40 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:babb7869-84b7-4f2b-be81-dc0e913f18d4","timestamp":"2023-12-11T01:18:42-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1001433","display":"1.5 ML cabazitaxel 40 MG/ML Injection"}]}}